We are live on ! Find out more
AV

ASR Vermogensbeheer Portfolio holdings

AUM $8.5B
1-Year Est. Return 25.14%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+25.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.5B
AUM Growth
-$96.1M
Cap. Flow
+$411M
Cap. Flow %
4.83%
Top 10 Hldgs %
34.38%
Holding
534
New
8
Increased
456
Reduced
39
Closed
2

Top Buys

1
AZN icon
AstraZeneca
AZN
+$162M
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$41.2M
3
NVDA icon
NVIDIA
NVDA
+$33.2M
4
UBS icon
UBS Group
UBS
+$19.4M
5
AAPL icon
Apple
AAPL
+$16.9M

Top Sells

1
META icon
Meta Platforms (Facebook)
META
+$17.1M
2
BDX icon
Becton Dickinson
BDX
+$8.94M
3
SLB icon
SLB Ltd
SLB
+$7.67M
4
GIB icon
CGI
GIB
+$4.75M
5
AMAT icon
Applied Materials
AMAT
+$3.24M

Sector Composition

1 Technology 30.92%
2 Financials 13.2%
3 Healthcare 11.8%
4 Consumer Discretionary 10.12%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTW icon
326
Willis Towers Watson
WTW
$27.7B
$2.74M 0.03%
9,442
+140
+2% +$43K
AEM icon
327
Agnico Eagle Mines
AEM
$68.5B
$2.72M 0.03%
13,446
– –
CM icon
328
Canadian Imperial Bank of Commerce
CM
$111B
$2.72M 0.03%
28,758
– –
EXPE icon
329
Expedia Group
EXPE
$32.3B
$2.69M 0.03%
11,644
+185
+2% +$45.4K
MET icon
330
MetLife
MET
$60.5B
$2.69M 0.03%
37,994
+459
+1% +$34.4K
TROW icon
331
T. Rowe Price
TROW
$25.1B
$2.68M 0.03%
29,715
+1,444
+5% +$140K
AVY icon
332
Avery Dennison
AVY
$12.3B
$2.59M 0.03%
14,975
+68
+0.5% +$12.5K
BNS icon
333
Scotiabank
BNS
$110B
$2.54M 0.03%
36,686
– –
MLM icon
334
Martin Marietta Materials
MLM
$33.8B
$2.53M 0.03%
4,290
+979
+30% +$625K
PAYX icon
335
Paychex
PAYX
$40.7B
$2.52M 0.03%
27,363
+549
+2% +$54.3K
LII icon
336
Lennox International
LII
$18.9B
$2.52M 0.03%
5,422
+96
+2% +$49.4K
COIN icon
337
Coinbase
COIN
$41.4B
$2.51M 0.03%
14,389
+238
+2% +$46.8K
CRH icon
338
CRH
CRH
$68.8B
$2.51M 0.03%
23,852
+3,259
+16% +$383K
MKC icon
339
McCormick & Company Non-Voting
MKC
$13.9B
$2.51M 0.03%
49,678
+2,258
+5% +$144K
NTRA icon
340
Natera
NTRA
$38.9B
$2.49M 0.03%
12,427
+221
+2% +$47.6K
WST icon
341
West Pharmaceutical
WST
$25.3B
$2.43M 0.03%
9,675
+162
+2% +$40.3K
HUM icon
342
Humana
HUM
$48B
$2.42M 0.03%
13,946
+245
+2% +$50.2K
EG icon
343
Everest Group
EG
$15.1B
$2.36M 0.03%
7,225
+6,146
+570% +$2.02M
P
344
Everpure Inc
P
$23.1B
$2.35M 0.03%
39,719
+767
+2% +$52K
FIS icon
345
Fidelity National Information Services
FIS
$21.7B
$2.28M 0.03%
48,501
+777
+2% +$41.8K
FISV
346
Fiserv Inc
FISV
$27B
$2.27M 0.03%
40,767
+654
+2% +$40.5K
DOC icon
347
Healthpeak Properties
DOC
$15.5B
$2.23M 0.03%
135,910
+2,997
+2% +$51.4K
CTAS icon
348
Cintas
CTAS
$81.8B
$2.16M 0.03%
12,800
+132
+1% +$25.3K
KHC icon
349
Kraft Heinz
KHC
$30.7B
$2.16M 0.03%
96,244
+10,154
+12% +$239K
EQR icon
350
Equity Residential
EQR
$25.9B
$2.16M 0.03%
36,557
+596
+2% +$36.8K
12 13
14
15 16

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

ASR Vermogensbeheer's Q1 2026 Portfolio in Review

As of Q1 2026, ASR Vermogensbeheer held 534 positions worth $8.5B, down 1.1% from $8.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ASR Vermogensbeheer deployed $411M of net new capital in Q1 2026, opening 8 new positions and adding to 456 existing holdings. Its largest new stake was AstraZeneca: 841,921 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $17.1M trimmed.

  • ASR Vermogensbeheer's largest Q1 2026 buy was AstraZeneca: 841,921 shares worth $163M.
  • ASR Vermogensbeheer added most to NVIDIA in Q1 2026, an estimated $33.2M increase.
  • ASR Vermogensbeheer's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $17.1M.
  • ASR Vermogensbeheer fully exited Amrize Ltd in Q1 2026, selling an estimated $1.58M.
  • ASR Vermogensbeheer's ten largest holdings make up 34% of its $8.5B portfolio in Q1 2026.
  • ASR Vermogensbeheer opened 8 new positions and closed 2 in Q1 2026.
  • ASR Vermogensbeheer's portfolio value fell 1.1% quarter-over-quarter to $8.5B.

Based on ASR Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.